Publications by authors named "Brian Schlain"

Claim this Profile
E
Evaluation of highly sensitive immunoassay technologies for quantitative measurements of sub-pg/mL levels of cytokines in human serum.
David Yeung, Shawn Ciotti, Shobha Purushothama, Elham Gharakhani, Geoffrey Kuesters, Brian Schlain

J Immunol Methods· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy.
Tatiana Plavina, Meena Subramanyam, Gary Bloomgren, Sandra Richman, Amy Pace, Brian Schlain

Ann Neurol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification.
Peter Lee, Tatiana Plavina, Albert Castro, Melissa Berman, Dipeshkumar Jaiswal, Brian Schlain

J Clin Virol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-site analytical validation of an assay to detect anti-JCV antibodies in human serum and plasma.
Tatiana Plavina, Melissa Berman, Moses Njenga, Mary Crossman, Michaela Lerner, Brian Schlain

J Clin Virol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of immunoassays to quantify the half-antibody exchange of an IgG4 antibody, natalizumab (Tysabri®) with endogenous IgG4.
Renée I Shapiro, Tatiana Plavina, Brian R Schlain, R Blake Pepinsky, Ellen A Garber

J Pharm Biomed Anal· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-JC virus antibodies: implications for PML risk stratification.
Leonid Gorelik, Michaela Lerner, Sarah Bixler, Mary Crossman, Brian Schlain

Ann Neurol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel gamma-fitting statistical method for anti-drug antibody assays to establish assay cut points for data with non-normal distribution.
Brian Schlain, Lakshmi Amaravadi, Jean Donley, Ananda Wickramasekera, Donald Bennett

J Immunol Methods· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis